Target intelligence / Profile preview

tumor protein D52-like 2 pseudogene

Overview

The "tumor protein D52-like 2 pseudogene" refers to a non-protein-coding genomic element related to the protein-coding gene tumor protein D52-like 2 (TPD52L2). While TPD52L2 is involved in cell proliferation, apoptosis, and is overexpressed in several cancers, pseudogenes do not produce functional protein products and are not considered therapeutic targets[1][3][5].

Beyond the preview

Go deeper on tumor protein D52-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tumor protein D52-like 2 pseudogene.

Explore the full profile